资金流向方面，今日该股主力资金净流入9094.36万元，其中，特大单净流入9842.86万元，大单资金净 流出748.49万元。近5日主力资金净流入9910.32万元。（数据宝） 漱玉平民今日涨停，全天换手率20.04%，成交额8.09亿元，振幅17.91%。龙虎榜数据显示，机构净卖出 2949.92万元，深股通净买入119.19万元，营业部席位合计净买入2597.67万元。 深交所公开信息显示，当日该股因日收盘价涨幅达20.00%上榜，机构专用席位净卖出2949.92万元，深 股通净买入119.19万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交2.46亿元，其中，买入成交额为1.22亿 元，卖出成交额为1.24亿元，合计净卖出233.07万元。 具体来看，今日上榜的营业部中，共有3家机构专用席位现身，即卖三、卖四、卖五，合计买入金额 2758.71万元，卖出金额5708.64万元，合计净卖出2949.92万元，深股通为第一大买入营业部及第一大卖 出营业部，买入金额为4047.42万元，卖出金额为3930.23万元，合计净买入119.19万元。 | 买/ | 会员营业部名称 | 买入金额（万 ...

证券之星消息，12月18日医药商业板块较上一交易日上涨3.9%，漱玉平民领涨。当日上证指数报收于 3876.37，上涨0.16%。深证成指报收于13053.98，下跌1.29%。医药商业板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 从资金流向上来看，当日医药商业板块主力资金净流入8.88亿元，游资资金净流出3.41亿元，散户资金 净流出5.48亿元。医药商业板块个股资金流向见下表： ...

301017 漱玉平民 18.04 20.04 20.03 920116 星图测控 88.28 20.04 6.21 （文章来源：证券时报网） MACD金叉信号形成，这些股涨势不错！ MACD金叉信号形成，这些股涨势不错！ 证券时报·数据宝统计，截至（12月18日）收盘，沪指报3876.37点，涨6.09点，涨幅为0.16%；深成指报 13053.97点，跌170.54点，跌幅为1.29%；创业板指报3107.06点，跌68.84点，跌幅为2.17%。个股方 面，今日79只A股换手率超过20%，其中，C元创、三羊马等3只个股换手率达五成以上，半数筹码易 主。（数据宝） 12月18日两市换手率居前个股一览 | 证券代码 | 证券简称 | 收盘价（元） | 换手率（%） | 涨跌幅（%） | | --- | --- | --- | --- | --- | | 001325 | C元创 | 67.23 | 78.03 | 171.64 | | 001317 | 三羊马 | 53.50 | 71.27 | -6.47 | | 001208 | 华菱线缆 | 21.25 | 57.33 | 2.16 | | 92009 ...

Group 1 - The family doctor concept sector rose by 3.86%, ranking second among concept sectors, with 22 stocks increasing, including a 20% limit up for Shuyupingmin and a limit up for Meinian Health [1] - The top gainers in the family doctor sector included Haixia Innovation, Weining Health, and Sichuang Medical, with increases of 16.39%, 11.11%, and 5.77% respectively [1] - The sector saw a net inflow of 1.544 billion yuan from main funds, with 18 stocks receiving net inflows, and five stocks exceeding 50 million yuan in net inflow [2] Group 2 - The leading stocks in terms of net inflow ratio were Haixia Innovation, Meinian Health, and Weining Health, with net inflow ratios of 14.36%, 13.05%, and 12.89% respectively [3] - The top three stocks by main fund inflow were Haixia Innovation with 489 million yuan, Meinian Health with 415 million yuan, and Weining Health with 347 million yuan [3][4] - The family doctor concept sector had a total of 15 stocks with significant net inflows, indicating strong investor interest [2][3]

Group 1 - The three major indices showed mixed performance, with the Shanghai Composite Index up 0.16%, while the Shenzhen Component Index and the ChiNext Index fell by 1.29% and 2.17% respectively, with a total trading volume of approximately 1.66 trillion yuan [2] - The pharmaceutical retail sector saw a resurgence, with companies like Huaren Health and Shuyuan Pingmin rising by 20%, and Yixin Tang increasing by 10%, indicating strong market interest [2] - Ant Group announced an upgrade of its AI health application to "Ant Ai Fu," focusing on a "health+" strategy, which aims to assist users in managing their health like a personal friend [2] Group 2 - The commercial aerospace sector remains active, with Tianyin Electromechanical rising over 16% and Aerospace Huanyu increasing by 14.71%, reflecting investor confidence in the industry [3] - The Long March 12A reusable rocket, developed by China Aerospace Science and Technology Corporation, is set for its historic first launch in December 2025, marking a significant milestone in China's space endeavors [3] - A report from Huaxi Securities highlights a shift in the commercial aerospace sector towards reusable manufacturing, with companies like SpaceX leading the way in reducing costs through increased reuse and launch frequency [3] Group 3 - The Central Economic Work Conference emphasized expanding domestic demand as a top priority for 2025, focusing on structural changes in consumption to stimulate growth [4] - Bank stocks performed well, with Shanghai Bank, Chongqing Rural Commercial Bank, and Suzhou Bank showing positive movements, indicating investor confidence in the banking sector [4] Group 4 - CICC's report forecasts that listed banks will see revenue growth rates of 2.5% and 3.6% for 2026 and 2027 respectively, with net profit growth rates of 1.9% and 2.6% [5] - The battery, AI, and PCB sectors experienced collective declines, with companies like Huasheng Lithium Battery dropping over 10%, indicating potential challenges in these industries [5] - Other sectors such as brokerage, automotive, liquor, and semiconductors also faced downturns, with notable declines in stocks like Muxi and BYD [5]

Market Overview - A-shares showed mixed performance on December 18, with the Shanghai Composite Index rising by 0.16% to 3876.37 points, while the Shenzhen Component Index fell by 1.29% to 13053.97 points, and the ChiNext Index dropped by 2.17% to 3107.06 points [1] - The total trading volume in the Shanghai and Shenzhen markets reached 1.66 trillion, with nearly 2900 stocks rising [1] Sector Performance Banking Sector - Bank stocks experienced a broad increase, with Shanghai Bank and Chongqing Rural Commercial Bank rising over 3% [1] Retail Sector - Retail concepts showed strength, with Central Plaza and Shanghai Jiubai hitting the daily limit [1] Commercial Aerospace - The commercial aerospace sector was active, with multiple stocks including Shengyang Technology and Shunhao Co. hitting the daily limit [1][2] Pharmaceutical Sector - The pharmaceutical sector continued to perform well, with stocks like Luyan Pharmaceutical and Zhongyao Holdings hitting the daily limit [1][3] Consumer Sector - The consumer sector, including retail, apparel, and food and beverage, led the gains, with stocks like Baida Group achieving six consecutive limits [1][4] Institutional Insights Economic Policy Outlook - Everbright Securities anticipates a favorable cross-year market for A-shares, supported by ongoing domestic economic policies and historical performance trends [5] - Huaxi Securities suggests focusing on the consumer sector as technology rotation slows down, with an emphasis on the high-low cut logic [6] - Bank of China Securities views A-shares as being in a "bull market continuation" phase, highlighting the importance of technology and anti-involution themes for future investment [7]

Market Overview - A-shares experienced slight fluctuations in early trading, with major indices showing mixed results; the Shanghai Composite Index, North China 50, and CSI 1000 slightly rose, while the Shenzhen Component, Sci-Tech 50, and ChiNext Index slightly declined [1] - The number of rising stocks significantly outnumbered declining ones, and trading volume remained stable [1] Commercial Aerospace Sector - The commercial aerospace and satellite navigation concept stocks were active, with Starry Technology hitting a 30% limit up, Tianyin Electromechanical quickly reaching a 20% limit up, and several other stocks also experiencing strong gains [2] - Aerospace equipment, military electronics, military information technology, and large aircraft sectors showed strong upward momentum, with multiple stocks hitting limit up [5] Satellite Communication Development - The Ministry of Industry and Information Technology proposed that by 2030, the satellite communication management system and policies will be further improved, with over 10 million satellite communication users expected [5] - The GW constellation plan led by China Satellite Network Group has launched a total of 116 satellites as of November, which is less than 1% of the planned total of 12,992 satellites [5] - According to the International Telecommunication Union, 10% of the satellite deployment (approximately 1,300 satellites) must be completed by 2026 to meet frequency resource application requirements [5] Pharmaceutical Sector - Pharmaceutical stocks collectively strengthened in the morning, with the pharmaceutical commercial sector leading the gains, and the sector index rising nearly 3% at one point [6] - Notable stocks included Huaren Health hitting a 20% limit up, and Luyan Pharmaceutical achieving a limit up for the second consecutive day, reaching an 8.5-year high [6] - The new national medical insurance drug list, which adds 114 new drugs including 50 innovative drugs, will be implemented nationwide on January 1, 2026 [6] Industry Consolidation - Domestic pharmaceutical distribution industry still has significant room for improvement in market concentration compared to the 96% market share of the top three pharmaceutical distribution companies in the U.S. [7] - The new round of state-owned enterprise reforms emphasizing professional integration in the pharmaceutical health sector is expected to accelerate mergers and acquisitions in the pharmaceutical commercial sector [7]

Market Overview - Major indices opened lower on December 18 but rebounded, with the Shanghai Composite Index turning positive by the time of reporting [1] - Sectors such as securities, coal, and oil saw significant gains, while CPO concepts, aquaculture, hotel and catering, semiconductors, and building materials faced declines [1] Healthcare Sector - The healthcare commercial concept continued to strengthen, with Huaren Health (301408) hitting a 20% limit up, and other companies like Luyuan Pharmaceutical and Zhongyao Holdings also reaching their limit up [1] AI and Financial Services - Ant Group's AI health app "Antifufu" saw a surge in downloads, ranking third on the Apple app chart, with over 15 million monthly active users and over 5 million health inquiries daily [3] - China International Capital Corporation (CICC) announced plans to merge with Dongxing Securities and Xinda Securities through a share swap, with CICC's A-shares set to be suspended from trading starting November 20, 2025, and resuming on December 18, 2025 [3] IP Economy - The IP economy concept was active, with companies like Guobo Co. and Sanxiang Impression hitting the limit up, while others like Deyi Cultural and Chuangyuan Co. also saw gains [5] - The Ministry of Commerce and other departments issued a notice to enhance collaboration between commerce and finance to boost consumption, focusing on new consumption models such as green consumption and AI + consumption [5] - The market for the "Guzi economy" is projected to reach 168.9 billion yuan in 2024, a 40.63% increase from 2023, indicating rapid growth in related sectors [5] Retail Sector Trends - Dongwu Securities highlighted that 2025 will be a significant year for retail reform, with traditional retailers improving product and service quality through adjustments [7] - The focus on enhancing product quality in the retail sector is supported by policies encouraging such improvements, particularly in less competitive lower-tier markets [7] - Kaifeng Securities noted that offline retail businesses are transitioning from selling products to offering services and experiences, leveraging their advantages to attract traffic [7]

Group 1 - The pharmaceutical sector showed strong performance at the beginning of the trading session, with significant gains observed in various companies [1] - Huaren Health experienced a rise of over 15%, indicating strong investor interest and market confidence [1] - Other companies such as Luyuan Pharmaceutical and Zhongyao Holdings reached their daily limit up, reflecting a bullish trend in the sector [1] Group 2 - Companies like Dajia Weikang, Renmin Tongtai, and Shuyupingmin also saw increases, contributing to the overall positive sentiment in the pharmaceutical industry [1]

| 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2025-113 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 关于为控股子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、担保情况概述 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于 2025 年 1 月 21 日召开第 四届董事会第三次会议，于 2025 年 2 月 6 日召开 2025 年第一次临时股东大会，审议通过 了《关于 2025 年度公司及子公司向银行等机构申请综合授信额度及提供担保的议案》，同 意公司及子公司 2025 年度对合并报表范围内各级子公司提供的担保额度为人民币 167,011.00 万元。其中公司向控股子公司漱玉医药物流（辽宁）有限公司（以下简称"辽 宁物流"）提供不超过 6,000 万元的担保额度。担保额度有效期自 2025 年第一次临时股东 大会审议通过之日起十二个月。具体内容详见公司于 2025 年 1 月 22 日和 2025 年 2 ...